# EDGAR Filing Document

**Accession Number:** 0002093501
**File Stem:** 0002093501-26-000002
**Filing Date:** 2026-3
**Character Count:** 12229
**Document Hash:** 88d95115b1d40f8cf785b776b0a46502
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002093501-26-000002.hdr.sgml**: 20260318

**ACCESSION NUMBER**: 0002093501-26-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260318

**FILED AS OF DATE**: 20260318

**DATE AS OF CHANGE**: 20260318

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Murthy Rohith
- **CENTRAL INDEX KEY:** 0002093501

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41838
- **FILM NUMBER:** 26771211

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 70 SHENTON WAY, #18-15
- **STREET 2:** EON SHENTON
- **CITY:** SINGAPORE
- **PROVINCE COUNTRY:** U0
- **ZIP:** 079118
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MoneyHero Ltd
- **CENTRAL INDEX KEY:** 0001974044
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 70 SHENTON WAY, #18-15
- **CITY:** SINGAPORE
- **STATE:** U0
- **ZIP:** 079118
- **BUSINESS PHONE:** 65-6322-4392

**MAIL ADDRESS:**
- **STREET 1:** 70 SHENTON WAY, #18-15
- **CITY:** SINGAPORE
- **STATE:** U0
- **ZIP:** 079118

## Ex-24

**POWER OF ATTORNEY**

(For Executing Forms 3, 4, and 5)

Know all by these presents, that the undersigned hereby constitutes and appoints each of YAM Wing Chu Judy, CHANG Jeanie, and YIP Ming Hei Jasper of MoneyHero Limited (the "***Company***"), signing individually, the undersigned's true and lawful attorneys-in-fact and agents to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the Securities and Exchange Commission (the "***SEC***") Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "***Exchange Act***"), and the rules thereunder, in the undersigned's capacity as an officer or director of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to execute such Forms 3, 4 or 5 (including amendments thereto), and timely file such forms with the SEC and any stock exchange or any similar authority; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in the attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is the Company assuming) any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below.

---

| | |
|:---|:---|
| Date: March 5, 2026 | Date: March 5, 2026 |
| By: | /s/ Rohith MURTHY |
|  | Name: Rohith MURTHY |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Murthy Rohith<br><sub>(Last) (First) (Middle)</sub><br>C/O MONEYHERO LIMITED<br>70 SHENTON WAY  #18-15, EON SHENTON<br><sub>(Street)</sub><br>SINGAPORE, SINGAPORE S079118<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>MoneyHero Ltd [ MNY ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Executive Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Class A Ordinary Shares | 92653<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Share Option (right to buy) | <sup>(2)</sup> | 2033-01-01 | Class A Ordinary Shares | 194085 | $0.0003 | D |  |
| Warrants (Class A-1) | <sup>(3)(4)</sup> | 2027-10-14 | Class A Ordinary Shares | 6965<sup>(3)(4)</sup> | <sup>(3)(4)</sup> | D |  |
| Warrants (Class A-2) | <sup>(5)(6)</sup> | 2027-10-14 | Class A Ordinary Shares | 2321<sup>(5)(6)</sup> | <sup>(5)(6)</sup> | D |  |
| Warrants (Class A-3) | <sup>(7)(8)</sup> | 2027-10-14 | Class A Ordinary Shares | 2321<sup>(7)(8)</sup> | <sup>(7)(8)</sup> | D |  |

---

### Footnotes:

(1) Includes 91,117 restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one Class A ordinary share of the Issuer upon settlement. 60,683 RSUs have fully vested as of the date hereof, and the remaining 30,434 RSUs will vest on February 16, 2027, subject to the Reporting Person's continued service with the Issuer through such vesting date.

(2) The shares subject to the option are fully vested.

(3) Represents 22,674 Class A-1 warrants, each exercisable for 0.307212 Class A ordinary shares at an exercise price of $2.9899 for such fractional Class A ordinary share, which is equivalent to 6,965.7 Class A ordinary shares at an exercise price of $9.4394 per Class A ordinary share. The Class A-1 warrants were originally issued prior to 2022 and exercisable for the shares of our predecessor Company, CompareAsia Group Capital Limited. In connection with the deSPAC the Class A-1 warrants were issued automatically pursuant to the Deed dated October 14, 2022, as supplemented on May 25, 2023 to replace these prior warrants, which were cancelled. The Class A-1 warrants expire on October 14, 2027. The Class A-1 warrants are subject to adjustment on the same basis as the public warrants, as further described in the Class A Warrant Agreement. No fractional Class A ordinary shares shall be issued upon exercise of the Class A-1 warrants. (footnote continued.)

(4) (footnote continued.) The Class A-1 warrants are fully vested and non-transferrable without the prior written consent of the Company, except to affiliates and other customary permitted transferees.

(5) Represents 7,558 Class A-2 warrants, each exercisable for 0.307212 Class A ordinary shares at an exercise price of $5.9798 for such fractional Class A ordinary share, which is equivalent to 2,321.9 Class A ordinary shares at an exercise price of $19.4647 per Class A ordinary share. The Class A-2 warrants were originally issued prior to 2022 and exercisable for the shares of our predecessor Company, CompareAsia Group Capital Limited. In connection with the deSPAC the Class A-2 warrants were issued automatically pursuant to the Deed dated October 14, 2022, as supplemented on May 25, 2023 to replace these prior warrants, which were cancelled. The Class A-2 warrants expire on October 14, 2027. The Class A-2 warrants are subject to adjustment on the same basis as the public warrants, as further described in the Class A Warrant Agreement. No fractional Class A ordinary shares shall be issued upon exercise of the Class A-2 warrants. (footnote continued.)

(6) (footnote continued.) The Class A-2 warrants are fully vested and non-transferrable without the prior written consent of the Company, except to affiliates and other customary permitted transferees.

(7) Represents 7,558 Class A-3 warrants, each exercisable for 0.307212 Class A ordinary shares at an exercise price of $8.9697 for such fractional Class A ordinary share, which is equivalent to 2,321.9 Class A ordinary shares at an exercise price of $29.1971 per Class A ordinary share. The Class A-3 warrants were originally issued prior to 2022 and exercisable for the shares of our predecessor Company, CompareAsia Group Capital Limited. In connection with the deSPAC the Class A-3 warrants were issued automatically pursuant to the Deed dated October 14, 2022, as supplemented on May 25, 2023 to replace these prior warrants, which were cancelled. The Class A-3 warrants expire on October 14, 2027. The Class A-3 warrants are subject to adjustment on the same basis as the public warrants, as further described in the Class A Warrant Agreement. No fractional Class A ordinary shares shall be issued upon exercise of the Class A-3 warrants. (footnote continued.)

(8) (footnote continued.) The Class A-3 warrants are fully vested and non-transferrable without the prior written consent of the Company, except to affiliates and other customary permitted transferees.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Ming Hei Jasper Yip, Attorney-in-Fact  
**Date:** 2026-03-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**